RNASE2 and gastric cancer: The results revealed that GC patients with a higher expression of FABP4, PI15, RNASE2, CGB5, INHBE, DUSP1, and CD36 showed significantly poorer OS than those with low expression, while patients with a higher expression of RLN2 showed the opposite trend.